240 related articles for article (PubMed ID: 21167518)
1. Metastasectomy after targeted therapy in patients with advanced renal cell carcinoma.
Karam JA; Rini BI; Varella L; Garcia JA; Dreicer R; Choueiri TK; Jonasch E; Matin SF; Campbell SC; Wood CG; Tannir NM
J Urol; 2011 Feb; 185(2):439-44. PubMed ID: 21167518
[TBL] [Abstract][Full Text] [Related]
2. Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy.
Naitoh J; Kaplan A; Dorey F; Figlin R; Belldegrun A
J Urol; 1999 Jul; 162(1):46-50. PubMed ID: 10379737
[TBL] [Abstract][Full Text] [Related]
3. Multi-modal treatment for metastatic renal cancer: the role of surgery.
Russo P
World J Urol; 2010 Jun; 28(3):295-301. PubMed ID: 20364382
[TBL] [Abstract][Full Text] [Related]
4. Surgery for metastases of renal cell carcinoma: outcome of treatments and preliminary assessment of Leuven-Udine prognostic groups in the targeted therapy era.
Tornberg SV; Visapää H; Kilpeläinen TP; Taari K; Järvinen R; Erkkilä K; Nisen H; Järvinen P
Scand J Urol; 2018; 52(5-6):419-426. PubMed ID: 30663485
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of complete metastasectomy in metastatic renal cell carcinoma patients: The Canadian Kidney Cancer information system experience.
Dragomir A; Nazha S; Wood LA; Rendon RA; Finelli A; Hansen A; So AI; Kollmannsberger C; Basappa NS; Pouliot F; Soulières D; Heng DYC; Kapoor A; Tanguay S
Urol Oncol; 2020 Oct; 38(10):799.e1-799.e10. PubMed ID: 32778475
[TBL] [Abstract][Full Text] [Related]
6. Prospective assessment of systemic therapy followed by surgical removal of metastases in selected patients with renal cell carcinoma.
Daliani DD; Tannir NM; Papandreou CN; Wang X; Swisher S; Wood CG; Swanson DA; Logothetis CJ; Jonasch E
BJU Int; 2009 Aug; 104(4):456-60. PubMed ID: 19338544
[TBL] [Abstract][Full Text] [Related]
7. Predictive factors for recurrence after complete metastasectomy in patients with metastatic renal cell carcinoma in the targeted therapy era.
Takagi T; Fukuda H; Ishihara H; Yoshida K; Kondo T; Kobayashi H; Iizuka J; Okumi M; Ishida H; Omae K; Tanabe K
Urol Oncol; 2020 May; 38(5):515-520. PubMed ID: 32146128
[TBL] [Abstract][Full Text] [Related]
8. The role of metastasectomy in renal cell carcinoma in the era of targeted therapy.
Ljungberg B
Curr Urol Rep; 2013 Feb; 14(1):19-25. PubMed ID: 23212738
[TBL] [Abstract][Full Text] [Related]
9. Predictors, utilization patterns, and overall survival of patients undergoing metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy.
Sun M; Meyer CP; Karam JA; de Velasco G; Chang SL; Pal SK; Trinh QD; Choueiri TK
Eur J Surg Oncol; 2018 Sep; 44(9):1439-1445. PubMed ID: 29935840
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Local Intervention Combined with Targeted Therapy on Metastatic Renal Cell Carcinoma.
Li JR; Ou YC; Yang CK; Wang SS; Chen CS; Ho HC; Cheng CL; Yang CR; Chen CC; Wang SC; Lin CY; Hung SC; Hsu CY; Chiu KY
Anticancer Res; 2018 Sep; 38(9):5339-5345. PubMed ID: 30194186
[TBL] [Abstract][Full Text] [Related]
11. Targeted therapy after complete resection of metastatic lesions in metastatic renal cell carcinoma.
Park YH; Jung JW; Lee BK; Lee S; Jeong SJ; Byun SS; Lee SE
Int J Urol; 2015 Feb; 22(2):153-7. PubMed ID: 25421791
[TBL] [Abstract][Full Text] [Related]
12. No role of adjuvant systemic therapy after complete metastasectomy in metastatic renal cell carcinoma?
Kwak C; Park YH; Jeong CW; Lee SE; Ku JH
Urol Oncol; 2007; 25(4):310-6. PubMed ID: 17628297
[TBL] [Abstract][Full Text] [Related]
13. Comparative Effectiveness of Initial Surgery vs Initial Systemic Therapy for Metastatic Kidney Cancer in the Targeted Therapy Era: Analysis of a Population-based Cohort.
Macleod LC; Odisho AY; Tykodi SS; Holt SK; Harper JD; Gore JL
Urology; 2018 Mar; 113():146-152. PubMed ID: 29174942
[TBL] [Abstract][Full Text] [Related]
14. Role of metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy.
Kim DY; Karam JA; Wood CG
World J Urol; 2014 Jun; 32(3):631-42. PubMed ID: 24744223
[TBL] [Abstract][Full Text] [Related]
15. Cytoreductive nephrectomy with thrombectomy before targeted therapy improves survival for metastatic renal cell carcinoma with venous tumor thrombus: a single-center experience.
Qi N; Wu P; Chen J; Li T; Ning X; Wang J; Gong K
World J Surg Oncol; 2017 Jan; 15(1):4. PubMed ID: 28056988
[TBL] [Abstract][Full Text] [Related]
16. Surgical treatment of atypical metastasis from renal cell carcinoma (RCC).
Antonelli A; Arrighi N; Corti S; Legramanti S; Zanotelli T; Cozzoli A; Cunico SC; Simeone C
BJU Int; 2012 Dec; 110(11 Pt B):E559-63. PubMed ID: 22639956
[TBL] [Abstract][Full Text] [Related]
17. Surgical outcomes after cytoreductive nephrectomy with inferior vena cava thrombectomy.
Westesson KE; Klink JC; Rabets JC; Fergany AF; Klein EA; Stephenson AJ; Rini BI; Navia J; Krishnamurthi V
Urology; 2014 Dec; 84(6):1414-9. PubMed ID: 25440988
[TBL] [Abstract][Full Text] [Related]
18. Resection of metastasis and local recurrences of renal cell carcinoma after presurgical targeted therapy: probability of complete local control and outcome.
Brehmer B; Kauffmann C; Blank C; Heidenreich A; Bex A
World J Urol; 2016 Aug; 34(8):1061-6. PubMed ID: 27287888
[TBL] [Abstract][Full Text] [Related]
19. Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery.
Ghavamian R; Cheville JC; Lohse CM; Weaver AL; Zincke H; Blute ML
J Urol; 2002 Aug; 168(2):454-9. PubMed ID: 12131287
[TBL] [Abstract][Full Text] [Related]
20. Role of targeted therapy in combination with surgery in renal cell carcinoma.
Bex A; Powles T; Karam JA
Int J Urol; 2016 Jan; 23(1):5-12. PubMed ID: 26238981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
